Results 121 to 130 of about 5,571 (181)
Alterations in GABAergic Interneurons, Neuroinflammation, and Epigenetics: Potential Targets for Therapeutic Strategies in Schizophrenia. [PDF]
Curr NeuropharmacolMatrisciano F +4 more
europepmc +1 more source
Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control. [PDF]
Pharmacol RevBanks ML +8 more
europepmc +1 more source
Notes on Alcoholism and Drug Abuse: Phencyclidine (PCP) Abuse.
The Western journal of medicine, 2010 openaire +1 more source
Phencyclidine Abuse Mimicking Head Injury
JAMA - Journal of the American Medical Association, 1980 Phencyclidine hydrochloride (PCP) is a psychoactive drug that in small doses produces agitation, excitement, and disorientation, but in larger doses results in stupor, convulsions, coma, and death. Two accident victims under the effects of phencyclidine were in coma. A history of phencyclidine abuse was not initially available in either instance.
R L, Corales, K I, Maull, D P, Becker
exaly +5 more sources
Growing Abuse of Phencyclidine: California “Angel Dust”
New England Journal of Medicine, 1977 N C, Jain, R D, Budd, B S, Budd
exaly +4 more sources
Comparison of Antidepressant‐Like and Abuse‐Related Effects of Phencyclidine in Rats [PDF]
Drug Development Research, 2014 Preclinical Research N ‐methyl‐D‐aspartate ( NMDA ) receptor antagonists, such as ketamine, have emerged as novel candidate treatments for major depressive disorder, but abuse potential of these agents is a concern.
Todd M Hillhouse +2 more
exaly +2 more sources